Mol. Cell. Biol., 01 1998, 122-129, Vol 18, No. 1
Copyright © 1998, American Society for Microbiology

The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX

RK Slany, C Lavau and ML Cleary
Department of Pathology, Stanford University Medical Center, California 94305, USA.

The HRX gene (also called MLL, ALL-1, and Htrx) at chromosome band 11q23 is associated with specific subsets of acute leukemias through translocations that result in its fusion with a variety of heterologous partners. Two of these partners, ENL and AF9, code for proteins that are highly similar to each other and as fusions with HRX induce myeloid leukemias in mice as demonstrated by retroviral gene transfer and knock- in experiments, respectively. In the present study, a structure- function analysis was performed to determine the molecular requirements for in vitro immortalization of murine myeloid cells by HRX-ENL. Deletions of either the AT hook motifs or the methyltransferase homology domain of HRX substantially impaired the transforming effects of HRX-ENL. The methyltransferase homology domain was shown to bind non- sequence specifically to DNA in vitro, providing evidence that the full transforming activity of HRX-ENL requires multiple DNA binding structures in HRX. The carboxy-terminal 84 amino acids of ENL, which encode two predicted helical structures highly conserved in AF9, were necessary and sufficient for transformation when they were fused to HRX. Similarly, mutations that deleted one or both of these conserved helices completely abrogated the transcriptional activation properties of ENL. This finding correlates, for the first time, a biological function of an HRX fusion partner with the transforming activity of the chimeric proteins. Our studies support a model in which HRX-ENL induces myeloid transformation by deregulating subordinate genes through a gain of function contributed by the transcriptional effector properties of ENL.

This article has been cited by other articles:

• Erfurth, F. E., Popovic, R., Grembecka, J., Cierpicki, T., Theisler, C., Xia, Z.-B., Stuart, T., Diaz, M. O., Bushweller, J. H., Zeleznik-Le, N. J. (2008). MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. Proc. Natl. Acad. Sci. USA 105: 7517-7522 [Abstract] [Full Text]  
• Mueller, D., Bach, C., Zeisig, D., Garcia-Cuellar, M.-P., Monroe, S., Sreekumar, A., Zhou, R., Nesvizhskii, A., Chinnaiyan, A., Hess, J. L., Slany, R. K. (2007). A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110: 4445-4454 [Abstract] [Full Text]  
• Liu, H., Cheng, E. H.-Y., Hsieh, J. J.-D. (2007). Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev. 21: 2385-2398 [Abstract] [Full Text]  
• Santillan, D. A., Theisler, C. M., Ryan, A. S., Popovic, R., Stuart, T., Zhou, M.-M., Alkan, S., Zeleznik-Le, N. J. (2006). Bromodomain and Histone Acetyltransferase Domain Specificities Control Mixed Lineage Leukemia Phenotype.. Cancer Res. 66: 10032-10039 [Abstract] [Full Text]  
• Hayette, S., Cornillet-Lefebvre, P., Tigaud, I., Struski, S., Forissier, S., Berchet, A., Doll, D., Gillot, L., Brahim, W., Delabesse, E., Magaud, J.-P., Rimokh, R. (2005). AF4p12, a Human Homologue to the furry Gene of Drosophila, as a Novel MLL Fusion Partner. Cancer Res. 65: 6521-6525 [Abstract] [Full Text]  
• Ayton, P. M., Chen, E. H., Cleary, M. L. (2004). Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein. Mol. Cell. Biol. 24: 10470-10478 [Abstract] [Full Text]  
• Bittner, C. B., Zeisig, D. T., Zeisig, B. B., Slany, R. K. (2004). Direct Physical and Functional Interaction of the NuA4 Complex Components Yaf9p and Swc4p. Eukaryot Cell 3: 976-983 [Abstract] [Full Text]  
• Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., Cleary, M. L. (2004). Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression. Mol. Cell. Biol. 24: 5639-5649 [Abstract] [Full Text]  
• Eguchi, M., Eguchi-Ishimae, M., Greaves, M. (2004). The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood 103: 3876-3882 [Abstract] [Full Text]  
• Daser, A., Rabbitts, T. H. (2004). Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18: 965-974 [Full Text]  
• Hirano, M., Kikuchi, Y., Nisitani, S., Yamaguchi, A., Satoh, A., Ito, T., Iba, H., Takatsu, K. (2004). Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes. Int Immunol 16: 747-757 [Abstract] [Full Text]  
• Yam, J. W. P., Jin, D.-Y., So, C. W., Chan, L. C. (2004). Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood 103: 1445-1453 [Abstract] [Full Text]  
• Deng, L.-W., Chiu, I., Strominger, J. L. (2004). MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc. Natl. Acad. Sci. USA 101: 757-762 [Abstract] [Full Text]  
• Zeisig, B. B., Milne, T., Garcia-Cuellar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., Hess, J. L., Slany, R. K. (2004). Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization. Mol. Cell. Biol. 24: 617-628 [Abstract] [Full Text]  
• Ayton, P. M., Cleary, M. L. (2003). Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17: 2298-2307 [Abstract] [Full Text]  
• Xia, Z.-B., Anderson, M., Diaz, M. O., Zeleznik-Le, N. J. (2003). MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc. Natl. Acad. Sci. USA 100: 8342-8347 [Abstract] [Full Text]  
• Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., Look, A. T. (2003). Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 102: 262-268 [Abstract] [Full Text]  
• So, C. W., Cleary, M. L. (2003). Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101: 633-639 [Abstract] [Full Text]  
• Mayotte, N., Roy, D.-C., Yao, J., Kroon, E., Sauvageau, G. (2002). Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Blood 100: 4177-4184 [Abstract] [Full Text]  
• Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., Ohki, M. (2002). Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100: 3710-3718 [Abstract] [Full Text]  
• Collins, E. C., Appert, A., Ariza-McNaughton, L., Pannell, R., Yamada, Y., Rabbitts, T. H. (2002). Mouse Af9 Is a Controller of Embryo Patterning, Like Mll, Whose Human Homologue Fuses with AF9 after Chromosomal Translocation in Leukemia. Mol. Cell. Biol. 22: 7313-7324 [Abstract] [Full Text]  
• So, C. W., Cleary, M. L. (2002). MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function. Mol. Cell. Biol. 22: 6542-6552 [Abstract] [Full Text]  
• DiMartino, J. F., Ayton, P. M., Chen, E. H., Naftzger, C. C., Young, B. D., Cleary, M. L. (2002). The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99: 3780-3785 [Abstract] [Full Text]  
• Zraly, C. B., Feng, Y., Dingwall, A. K. (2002). Genetic and Molecular Analysis of Region 88E9;88F2 in Drosophila melanogaster, Including the ear Gene Related to Human Factors Involved in Lineage-Specific Leukemias. Genetics 160: 1051-1065 [Abstract] [Full Text]  
• Birke, M., Schreiner, S., Garcia-Cuellar, M.-P., Mahr, K., Titgemeyer, F., Slany, R. K. (2002). The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res 30: 958-965 [Abstract] [Full Text]  
• Kawamata, S., Du, C., Li, K., Lavau, C. (2002). Notch1 Perturbation of Hemopoiesis Involves Non-Cell- Autonomous Modifications. J. Immunol. 168: 1738-1745 [Abstract] [Full Text]  
• Debernardi, S., Bassini, A., Jones, L. K., Chaplin, T., Linder, B., de Bruijn, D. R. H., Meese, E., Young, B. D. (2002). The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99: 275-281 [Abstract] [Full Text]  
• Luo, R. T., Lavau, C., Du, C., Simone, F., Polak, P. E., Kawamata, S., Thirman, M. J. (2001). The Elongation Domain of ELL Is Dispensable but Its ELL-Associated Factor 1 Interaction Domain Is Essential for MLL-ELL-Induced Leukemogenesis. Mol. Cell. Biol. 21: 5678-5687 [Abstract] [Full Text]  
• Fuchs, U., Rehkamp, G., Haas, O. A., Slany, R., Konig, M., Bojesen, S., Bohle, R. M., Damm-Welk, C., Ludwig, W.-D., Harbott, J., Borkhardt, A. (2001). The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia. Proc. Natl. Acad. Sci. USA 10.1073/pnas.121433898v1 [Abstract] [Full Text]  
• Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., Diaz, M. O. (2001). Protein Interactions of the MLL PHD Fingers Modulate MLL Target Gene Regulation in Human Cells. Mol. Cell. Biol. 21: 3589-3597 [Abstract] [Full Text]  
• Ernst, P., Wang, J., Huang, M., Goodman, R. H., Korsmeyer, S. J. (2001). MLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein. Mol. Cell. Biol. 21: 2249-2258 [Abstract] [Full Text]  
• Kuwada, N., Kimura, F., Matsumura, T., Yamashita, T., Nakamura, Y., Wakimoto, N., Ikeda, T., Sato, K., Motoyoshi, K. (2001). t(11;14)(q23;q24) Generates an MLL-Human Gephyrin Fusion Gene along with a de facto Truncated MLL in Acute Monoblastic Leukemia. Cancer Res. 61: 2665-2669 [Abstract] [Full Text]  
• DiMartino, J. F., Miller, T., Ayton, P. M., Landewe, T., Hess, J. L., Cleary, M. L., Shilatifard, A. (2000). A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96: 3887-3893 [Abstract] [Full Text]  
• Lavau, C., Luo, R. T., Du, C., Thirman, M. J. (2000). Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc. Natl. Acad. Sci. USA 10.1073/pnas.190167297v1 [Abstract] [Full Text]  
• MORGAN, H., SMITH, M., BURKE, Z., CARTER, D. (2000). The transactivation-competent carboxyl-terminal domain of AF-9 is expressed within a sexually dimorphic transcript in rat pituitary. FASEB J. 14: 1109-1116 [Abstract] [Full Text]  
• Shin Voo, K., Carlone, D. L., Jacobsen, B. M., Flodin, A., Skalnik, D. G. (2000). Cloning of a Mammalian Transcriptional Activator That Binds Unmethylated CpG Motifs and Shares a CXXC Domain with DNA Methyltransferase, Human Trithorax, and Methyl-CpG Binding Domain Protein 1. Mol. Cell. Biol. 20: 2108-2121 [Abstract] [Full Text]  
• Taki, T., Kano, H., Taniwaki, M., Sako, M., Yanagisawa, M., Hayashi, Y. (1999). AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl. Acad. Sci. USA 96: 14535-14540 [Abstract] [Full Text]  
• Adler, H. T., Chinery, R., Wu, D. Y., Kussick, S. J., Payne, J. M., Fornace, A. J. Jr., Tkachuk, D. C. (1999). Leukemic HRX Fusion Proteins Inhibit GADD34-Induced Apoptosis and Associate with the GADD34 and hSNF5/INI1 Proteins. Mol. Cell. Biol. 19: 7050-7060 [Abstract] [Full Text]  
• Du, C., Redner, R. L., Cooke, M. P., Lavau, C. (1999). Overexpression of Wild-Type Retinoic Acid Receptor alpha (RARalpha ) Recapitulates Retinoic Acid-Sensitive Transformation of Primary Myeloid Progenitors by Acute Promyelocytic Leukemia RARalpha -Fusion Genes. Blood 94: 793-802 [Abstract] [Full Text]  
• Bourachot, B., Yaniv, M., Muchardt, C. (1999). The Activity of Mammalian brm/SNF2alpha Is Dependent on a High-Mobility-Group Protein I/Y-Like DNA Binding Domain. Mol. Cell. Biol. 19: 3931-3939 [Abstract] [Full Text]  
• Taki, T., Shibuya, N., Taniwaki, M., Hanada, R., Morishita, K., Bessho, F., Yanagisawa, M., Hayashi, Y. (1998). ABI-1, a Human Homolog to Mouse Abl-Interactor 1, Fuses the MLL Gene in Acute Myeloid Leukemia With t(10;11)(p11.2;q23). Blood 92: 1125-1130 [Abstract] [Full Text]  
• De Vivo, I., Cui, X., Domen, J., Cleary, M. L. (1998). Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1. Proc. Natl. Acad. Sci. USA 95: 9471-9476 [Abstract] [Full Text]  
• Rekdal, C., Sjottem, E., Johansen, T. (2000). The Nuclear Factor SPBP Contains Different Functional Domains and Stimulates the Activity of Various Transcriptional Activators. J. Biol. Chem. 275: 40288-40300 [Abstract] [Full Text]  
• Caslini, C., Shilatifard, A., Yang, L., Hess, J. L. (2000). The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation. Proc. Natl. Acad. Sci. USA 97: 2797-2802 [Abstract] [Full Text]  
• Fuchs, U., Rehkamp, G., Haas, O. A., Slany, R., Konig, M., Bojesen, S., Bohle, R. M., Damm-Welk, C., Ludwig, W.-D., Harbott, J., Borkhardt, A. (2001). The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia. Proc. Natl. Acad. Sci. USA 98: 8756-8761 [Abstract] [Full Text]  
• Lavau, C., Luo, R. T., Du, C., Thirman, M. J. (2000). Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc. Natl. Acad. Sci. USA 97: 10984-10989 [Abstract] [Full Text]